Phythera Therapeutics Inc. — Form D

Phythera Therapeutics Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-16. The offering totals $468, of which $468 was reported sold. Industry: Biotechnology.

Offering

Filed: 2024-05-16
Form: D
Accession: 0002017198-24-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $468
Amount sold: $468
Investors: 10
Date of first sale: 2023-01-17
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-513537

Issuer

Name: Phythera Therapeutics Inc.
CIK: 0002017198
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 103 ROCKVIEW, IRVINE, CA, 92612
Phone: (510) 205-7828

Officers, directors & promoters (15)

Name	Role	Location
Charles S Irving, Ph.D.	Director	Irvine, CA
Igor O Nasonkin, Ph.D.	Director	Irvine, CA
Judith S Segall	Director	Irvine, CA
Hal S Sternberg, Ph.D.	Director	Irvine, CA
Charles S Irving, Ph.D.	Executive Officer	Irvine, CA
Igor O Nasonkin, Ph.D.	Executive Officer	Irvine, CA
Judith S Segall	Executive Officer	Irvine, CA
Hal S Sternberg, Ph.D.	Executive Officer	Irvine, CA
Ngoc T Tran	Executive Officer	Irvine, CA
Charles S Irving, Ph.D.	Promoter	Irvine, CA
Zamira Nazirova Nasonkin	Promoter	Irvine, CA
Igor O Nasonkin, Ph.D.	Promoter	Irvine, CA
Judith S Segall	Promoter	Irvine, CA
Hal S Sternberg, Ph.D.	Promoter	Irvine, CA
Ngoc T Tran	Promoter	Irvine, CA

More